Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 12 studies | 22% ± 5% | |
non-classical monocyte | 6 studies | 22% ± 5% | |
conventional dendritic cell | 5 studies | 30% ± 13% | |
epithelial cell of proximal tubule | 5 studies | 23% ± 8% | |
fibroblast | 5 studies | 18% ± 1% | |
macrophage | 5 studies | 17% ± 2% | |
plasmacytoid dendritic cell | 5 studies | 22% ± 4% | |
epithelial cell | 4 studies | 26% ± 5% | |
dendritic cell | 4 studies | 27% ± 7% | |
intermediate monocyte | 3 studies | 22% ± 6% | |
intestinal crypt stem cell | 3 studies | 20% ± 2% | |
hematopoietic stem cell | 3 studies | 17% ± 2% |
Insufficient scRNA-seq data for expression of DHRS4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 895.68 | 1445 / 1445 | 100% | 14.06 | 183 / 183 |
ovary | 100% | 695.06 | 180 / 180 | 100% | 13.29 | 429 / 430 |
liver | 100% | 1417.78 | 226 / 226 | 100% | 22.63 | 405 / 406 |
kidney | 100% | 1696.06 | 89 / 89 | 99% | 15.20 | 896 / 901 |
pancreas | 100% | 538.72 | 328 / 328 | 99% | 10.65 | 177 / 178 |
uterus | 100% | 599.55 | 170 / 170 | 99% | 15.12 | 456 / 459 |
thymus | 100% | 631.87 | 653 / 653 | 99% | 12.30 | 601 / 605 |
stomach | 100% | 619.35 | 359 / 359 | 99% | 12.87 | 284 / 286 |
intestine | 100% | 942.29 | 966 / 966 | 99% | 15.96 | 523 / 527 |
lung | 100% | 665.16 | 577 / 578 | 99% | 12.00 | 1147 / 1155 |
skin | 100% | 1001.36 | 1809 / 1809 | 99% | 10.83 | 466 / 472 |
prostate | 100% | 758.59 | 244 / 245 | 99% | 13.51 | 497 / 502 |
breast | 100% | 798.97 | 459 / 459 | 98% | 15.52 | 1101 / 1118 |
adrenal gland | 100% | 1051.43 | 258 / 258 | 98% | 11.33 | 225 / 230 |
bladder | 100% | 696.38 | 21 / 21 | 98% | 13.52 | 493 / 504 |
brain | 97% | 358.12 | 2561 / 2642 | 97% | 9.99 | 687 / 705 |
adipose | 100% | 742.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.83 | 29 / 29 |
spleen | 100% | 743.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.49 | 1 / 1 |
blood vessel | 100% | 613.22 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 906.18 | 800 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 11.35 | 79 / 80 |
heart | 99% | 671.41 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 430.99 | 839 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006066 | Biological process | alcohol metabolic process |
GO_0042574 | Biological process | retinal metabolic process |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0042180 | Biological process | cellular ketone metabolic process |
GO_0008202 | Biological process | steroid metabolic process |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005777 | Cellular component | peroxisome |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0005634 | Cellular component | nucleus |
GO_0016655 | Molecular function | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
GO_0033703 | Molecular function | 3beta-hydroxy-5beta-steroid dehydrogenase activity |
GO_0001758 | Molecular function | retinal dehydrogenase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0052650 | Molecular function | all-trans-retinol dehydrogenase (NADP+) activity |
GO_0018455 | Molecular function | alcohol dehydrogenase [NAD(P)+] activity |
GO_0000253 | Molecular function | 3-keto sterol reductase activity |
GO_0004090 | Molecular function | carbonyl reductase (NADPH) activity |
Gene name | DHRS4 |
Protein name | Dehydrogenase/reductase 4 Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase) (CR) (NADPH-dependent retinol dehydrogenase/reductase) (NRDR) (humNRDR) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (SCAD-SRL) (Short chain dehydrogenase/reductase family 25C member 2) (Protein SDR25C2) (Short-chain dehydrogenase/reductase family member 4) |
Synonyms | SDR25C2 UNQ851/PRO1800 |
Description | FUNCTION: NADPH-dependent oxidoreductase which catalyzes the reduction of a variety of compounds bearing carbonyl groups including ketosteroids, alpha-dicarbonyl compounds, aldehydes, aromatic ketones and quinones . Reduces 3-ketosteroids and benzil into 3beta-hydroxysteroids and R-benzoin, respectively, in contrast to the stereoselectivity of non-primate DHRS4s which produce 3alpha-hydroxysteroids and S-benzoin . Diplays low activity toward all-trans-retinal and no activity toward 9-cis-retinal as compared to non-primate mammals . In the reverse reaction, catalyze the NAD-dependent oxidation of 3beta-hydroxysteroids and alcohol, but with much lower efficiency . Involved in the metabolism of 3beta-hydroxysteroids, isatin and xenobiotic carbonyl compounds . .; FUNCTION: [Isoform 7]: No detected catalytic activity in vitro, possibly due to the lack of catalytic site. .; FUNCTION: [Isoform 8]: NADPH-dependent oxidoreductase which catalyzes the reduction of a variety of compounds bearing carbonyl groups including ketosteroids, alpha-dicarbonyl compounds, aldehydes, aromatic ketones and quinones. Involved in the metabolism of 3beta-hydroxysteroids, isatin and xenobiotic carbonyl compounds. Has a higher catalytic activity for xenobiotic alpha-dicarbonyl compounds, sucha as benzil, than isoform 1 and is involved in benzil detoxification. . |
Accessions | ENST00000397074.7 [Q9BTZ2-3] ENST00000558263.5 [Q9BTZ2-7] ENST00000313250.10 [Q9BTZ2-1] ENST00000397075.7 [Q9BTZ2-2] F5GWZ1 ENST00000647030.2 [Q9BTZ2-4] ENST00000543741.6 ENST00000558581.5 [Q9BTZ2-4] ENST00000710583.1 [Q9BTZ2-7] ENST00000710584.1 [Q9BTZ2-1] H0YNP7 ENST00000559975.1 ENST00000647154.2 [Q9BTZ2-3] Q9BTZ2 ENST00000646997.2 [Q9BTZ2-5] ENST00000645602.2 [Q9BTZ2-2] ENST00000559632.5 [Q9BTZ2-5] |